Usefulness of abciximab for treatment of early coronary artery stent thrombosis

Ivan P. Casserly, David Hasdai, Peter B. Berger, David Holmes, Robert S. Schwartz, Malcolm R. Bell

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The clinical and angiographic outcomes of 10 patients' who received abciximab as part of their therapy for early stent thrombosis was compared with 25 patients (using historical controls) who received conventional therapy. Although the angiographic outcome and the incidence of myocardial infarction in both groups was similar, there were no deaths or referral for emergency coronary bypass surgery in the abciximab-treated group versus 3 deaths and 10 referrals for emergency bypass surgery in the conventionally treated group.

Original languageEnglish (US)
Pages (from-to)981-985
Number of pages5
JournalAmerican Journal of Cardiology
Volume82
Issue number8
DOIs
StatePublished - Oct 15 1998

Fingerprint

Stents
Coronary Vessels
Emergencies
Thrombosis
Referral and Consultation
Myocardial Infarction
Incidence
Therapeutics
abciximab

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Usefulness of abciximab for treatment of early coronary artery stent thrombosis. / Casserly, Ivan P.; Hasdai, David; Berger, Peter B.; Holmes, David; Schwartz, Robert S.; Bell, Malcolm R.

In: American Journal of Cardiology, Vol. 82, No. 8, 15.10.1998, p. 981-985.

Research output: Contribution to journalArticle

Casserly, Ivan P. ; Hasdai, David ; Berger, Peter B. ; Holmes, David ; Schwartz, Robert S. ; Bell, Malcolm R. / Usefulness of abciximab for treatment of early coronary artery stent thrombosis. In: American Journal of Cardiology. 1998 ; Vol. 82, No. 8. pp. 981-985.
@article{f90757de3fbb4d9588a946cf52036bf7,
title = "Usefulness of abciximab for treatment of early coronary artery stent thrombosis",
abstract = "The clinical and angiographic outcomes of 10 patients' who received abciximab as part of their therapy for early stent thrombosis was compared with 25 patients (using historical controls) who received conventional therapy. Although the angiographic outcome and the incidence of myocardial infarction in both groups was similar, there were no deaths or referral for emergency coronary bypass surgery in the abciximab-treated group versus 3 deaths and 10 referrals for emergency bypass surgery in the conventionally treated group.",
author = "Casserly, {Ivan P.} and David Hasdai and Berger, {Peter B.} and David Holmes and Schwartz, {Robert S.} and Bell, {Malcolm R.}",
year = "1998",
month = "10",
day = "15",
doi = "10.1016/S0002-9149(98)00519-0",
language = "English (US)",
volume = "82",
pages = "981--985",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Usefulness of abciximab for treatment of early coronary artery stent thrombosis

AU - Casserly, Ivan P.

AU - Hasdai, David

AU - Berger, Peter B.

AU - Holmes, David

AU - Schwartz, Robert S.

AU - Bell, Malcolm R.

PY - 1998/10/15

Y1 - 1998/10/15

N2 - The clinical and angiographic outcomes of 10 patients' who received abciximab as part of their therapy for early stent thrombosis was compared with 25 patients (using historical controls) who received conventional therapy. Although the angiographic outcome and the incidence of myocardial infarction in both groups was similar, there were no deaths or referral for emergency coronary bypass surgery in the abciximab-treated group versus 3 deaths and 10 referrals for emergency bypass surgery in the conventionally treated group.

AB - The clinical and angiographic outcomes of 10 patients' who received abciximab as part of their therapy for early stent thrombosis was compared with 25 patients (using historical controls) who received conventional therapy. Although the angiographic outcome and the incidence of myocardial infarction in both groups was similar, there were no deaths or referral for emergency coronary bypass surgery in the abciximab-treated group versus 3 deaths and 10 referrals for emergency bypass surgery in the conventionally treated group.

UR - http://www.scopus.com/inward/record.url?scp=0032532073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032532073&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(98)00519-0

DO - 10.1016/S0002-9149(98)00519-0

M3 - Article

C2 - 9794358

AN - SCOPUS:0032532073

VL - 82

SP - 981

EP - 985

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8

ER -